Gornowicz-Porowska Justyna, Seraszek-Jaros Agnieszka, Bowszyc-Dmochowska Monika, Bartkiewicz Paweł, Kaczmarek Elżbieta, Dmochowski Marian
Autoimmune Blistering Dermatoses Section, Department of Dermatology, Poznan University of Medical Sciences, Poznan, Poland.
Department of Bioinformatics and Computational Biology, Poznan University of Medical Sciences, Poznan, Poland.
J Clin Lab Anal. 2018 May;32(4):e22336. doi: 10.1002/jcla.22336. Epub 2017 Sep 26.
Technical innovation of autoimmune blistering dermatoses (ABDs) diagnosis aimed at multiplex approach. Two multiparametric ELISA tests are commercially available for ABDs serology. The aim was to compare diagnostic accuracy of multiparametric and monospecific ELISAs and to examine the diagnostic value/agreement of multivariant ELISA in compliance with traditional diagnostic setup for ABDs.
In total, 128 sera from suspected ABDs patients were studied (27 sera in order to compare ELISAs). Multivariant ELISA (detection of IgG against desmoglein 1 and 3 - DSG1/3; BP180, BP230, envoplakin, type VII collagen), monovariant ELISA, and statistical analysis were performed.
With the use of sera from patients with suspected ABDs, the multiparametric ELISA yield an agreement of 84% with traditional stepwise diagnostics. Multivariant ELISA with BP180 and BP230 showed 87.5% and 80% sensitivity, 87.5% and 91% specificity, 87.5% reliability as well as 87.5% and 80% positive predictive value, 87.5% and 91% negative predictive value, respectively, in relation to monospecific ELISA. Multivariant ELISA with DSG1 and DSG3 showed 50% and 80% sensitivity, 100% and 80% specificity, 85% and 80% reliability as well as 100% and 57% positive predictive value, 82% and 92% negative predictive value, respectively, in relation to monospecific ELISA. A better rate of agreement was observed among ELISA systems with BP180 and BP230, than with ELISA systems with DSG1 and DSG3.
Multivariant ELISA test combined with clinical examinations and DIF is recommended as a minimal approach to diagnosing ABDs in ethnic Slavs.
自身免疫性水疱性皮肤病(ABDs)诊断的技术创新旨在采用多重检测方法。有两种多参数酶联免疫吸附测定(ELISA)检测可用于ABDs血清学检测。目的是比较多参数ELISA和单特异性ELISA的诊断准确性,并根据ABDs的传统诊断设置检查多变量ELISA的诊断价值/一致性。
共研究了128份疑似ABDs患者的血清(其中27份血清用于比较ELISA)。进行了多变量ELISA(检测抗桥粒芯糖蛋白1和3 - DSG1/3、BP180、BP230、内披蛋白、VII型胶原的IgG)、单变量ELISA及统计分析。
使用疑似ABDs患者的血清,多参数ELISA与传统逐步诊断的一致性为84%。与单特异性ELISA相比,针对BP180和BP230的多变量ELISA的灵敏度分别为87.5%和80%,特异性分别为87.5%和91%,可靠性分别为87.5%,阳性预测值分别为87.5%和80%,阴性预测值分别为87.5%和91%。针对DSG1和DSG3的多变量ELISA与单特异性ELISA相比,灵敏度分别为50%和80%,特异性分别为100%和80%,可靠性分别为85%和80%,阳性预测值分别为100%和57%,阴性预测值分别为82%和92%。观察到针对BP180和BP230的ELISA系统之间的一致性率高于针对DSG1和DSG3的ELISA系统。
建议将多变量ELISA检测与临床检查及直接免疫荧光检查相结合,作为诊断斯拉夫族ABDs的最低限度方法。